rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Acurx Pharmaceuticals, Inc.

ACXP · Nasdaq

Health CareBiotechnologyNot moving yet

ACXP stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 38.5% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
18% -12 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
19 (-2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

22 Apr – 21 Oct
16%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$165KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders19-2 on the quarter
New · exited2 · 4
Reported value$193K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 202631,099$48K00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202626,411$41K+1,592+6.4%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202616,205$25K00.0%
JANE STREET GROUP, LLCreduced · filed 14 Aug 202615,727$24K-38,915−71.2%
Prospect Financial Services LLCunchanged · filed 6 Aug 202613,785$21K00.0%
MORGAN STANLEYadded · filed 13 Aug 20267,500$12K+1,000+15.4%
Integrated Wealth Concepts LLCnew · filed 12 Aug 20264,729$7,330+4,729
Tower Research Capital LLC (TRC)added · filed 11 Aug 20262,744$4,253+1,713+166.1%
WELLS FARGO & COMPANYunchanged · filed 14 Aug 20262,300$3,56500.0%
Westside Investment Management, Inc.unchanged · filed 27 Jul 20261,650$2,55800.0%
31 Mar 2025 – 30 Jun 2026
81420Mar 25Jun 25Dec 25Mar 26Jun 26

Everyone who traded it

Carl Sailer Company insiderDirector · last 20 Apr 20264 · 0
David P. Luci Company insiderPresident and CEO · last 20 Apr 20263 · 0
Jack H. Dean Company insiderDirector · last 20 Apr 20261 · 0
James J. Donohue Company insiderDirector · last 20 Apr 20261 · 0
Joseph C. Scodari Company insiderDirector · last 20 Apr 20261 · 0
Robert G. Shawah Company insiderChief Financial Officer · last 20 Apr 20260 · 0
Robert J. Deluccia Company insiderDirector · last 20 Apr 20263 · 0
Thomas L. Harrison Company insiderDirector · last 20 Apr 20260 · 0

Same industry

MRNA ModernaLeading+168%
IOVA Iovance BiotherapeuticsLeading+134%
ABCL AbCellera BiologicsLeading+62%
ENTX Entera BioLeading+53%
HALO Halozyme TherapeuticsLeading+48%
XERS Xeris Biopharma HoldingsLeading+42%
XNCR XencorLeading+41%
HELP Helus PharmaLeading+37%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-154%
Share count trendFY 2025 · to 12 Mar 202621.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$7.6M

Analyst forecasts

No analyst forecasts yet.